The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.
The visiting critic discusses the importance of social design shaped by community partnerships, and a collaboration with AAP students and Black high schoolers in Brooklyn.
The environment surrounding the cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a new study by Weill Cornell Medicine investigators.
Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine.
A type of cell widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University.
Poor function of the gene SMC3 can lead to improper immune cell development, and to cancer, by disrupting how DNA is structured inside the cell nucleus, according to new research from Weill Cornell Medicine.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
A $10 million gift to the College of Architecture, Art and Planning has been given to the college by a multi-generational Cornellian family to name and permanently fund its NYC program.
The new, collaborative Precision Behavioral Health Initiative aims to use both smart devices and artificial intelligence to help individuals, and their doctors, monitor and manage behavioral health.
